Hostname: page-component-7479d7b7d-qlrfm Total loading time: 0 Render date: 2024-07-11T02:25:37.254Z Has data issue: false hasContentIssue false
  • English
  • Français

Expanding Roles of Hospital Epidemiology: Pharmacoepidemiology

Published online by Cambridge University Press:  21 June 2016

John p. Burke ,
Hugh H. Tilson  and
Richard Platt
John p. Burke*
Affiliation:
Division of infectious Diseases, LDS Hospital, Salt Lake City, Utah
Hugh H. Tilson
Affiliation:
Burroughs Wellcome Company, Research Triangle Park, North Carolina
Richard Platt
Affiliation:
Brigham and Women's Hospital, Boston, Massachusetts
*
Division of Infectious Diseases, LDS Hospital, 8th Avenue and C Street, Salt Lake City, UT 84143
Get access Rights & Permissions [Opens in a new window]

Extract

In the past few years, several hospital epidemiology programs in the United States have developed the capacity to monitor drug usage in hospitalized patients. This activity has been stimulated by a Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) mandate to monitor antimicrobial agents and also by the emergence of technology for automated medical record linkage. There is a growing recognition that these methods to link computerized pharmacy records and discharge diagnoses can be used to identify “signals” for side effects and toxicities of all drugs and not only just for antimicrobial agents. In addition, clinical trials designed to detect occurrences of adverse experiences with commonly used antimicrobials have led some hospital epidemiologists to seek collaboration with experts in the methodologies for study of drug usage and drug effects, i.e., pharmacoepidemiologists.

Type
Program Summaries
Information
Infection Control & Hospital Epidemiology , Volume 10 , Issue 6 , June 1989 , pp. 253 - 254
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Hartzema, AG, Porta, MS, Tilson, HH (eds): Pharmacoepidemiology: An Introduction. Cincinnati, Harvey Whitney Books Co. 1988.Google Scholar
2. Miller, RR, Greenblatt, DJ (eds): Drug Effects in Hospitalized Patients. New York, John Wiley & Sons, 1976.Google Scholar
3. U.S. Senate Committee on Labor and Human Resources, Subcommittee on Health and Scientific Research: Final Report of the Joint Commission on Prescription Drug Use. Washington. DC, Government Printing Office, 1980.Google Scholar
4. Jick, H, Madsen, S, Nudelman, PM. et al: Postmarketing follow-up at Group Health Cooperative of Puget Sound. Pharmacotherapy 1984; 4: 99–100.CrossRefGoogle ScholarPubMed
5. Cohen, MR: A compilation of abstracts and index published by the Boston Collaborative Drug Surveillance Program 1966-1985. Hosp Pharm 1986; 21: 497–559.Google Scholar
6. Platt, R, Stryker, WS, Komaroff, AL: Pharmacoepidemiology in hospitals using automated data systems. Am J Prev Med 1988; 4(suppl 1): 39–47.Google ScholarPubMed